Free Trial

Trillium, Analog Devices rise: General Motors, Lennar fall

Stocks that traded heavily or had substantial price changes Monday:

Pfizer Inc., up $1.21 to $49.93.

The Food and Drug Administration gave full approval to the COVID-19 vaccine the company developed with BioNTech.

Trillium Therapeutics Inc., up $11.50 to $17.59.

The developer of cancer treatments agreed to be acquired by Pfizer for more than $2 billion in cash.

DoorDash Inc., down $1 to $183.08.

A California judge struck down a ballot measure exempting app-based delivery and ride-hailing services from a law requiring drivers to be classified as employees.

General Motors Co., down 62 cents to $48.18.

The automaker is recalling all Chevrolet Bolt electric vehicles worldwide to fix a battery problem that could cause fires.

Madison Square Garden Entertainment Corp., up $10.12 to $72.55.

The company reported revenue that was higher than analysts were expecting as its venues resumed hosting live events.

Analog Devices Inc., up $2.99 to $169.63.

The chipmaker received antitrust clearance from Chinese regulators for its combination with Maxim Integrated Products.

Occidental Petroleum Corp., up $1.52 to $23.47.

Energy companies were broadly higher as crude oil prices regained some of the ground lost in recent days.

Lennar Corp., down 87 cents to $104.45.

Homebuilders were lower following a report that sales of previously occupied homes rose at a more moderate pace in July from a year ago.

Should you invest $1,000 in Trillium Therapeutics right now?

Before you consider Trillium Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trillium Therapeutics wasn't on the list.

While Trillium Therapeutics currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
General Motors (GM)
4.2719 of 5 stars
$51.80+1.6%0.93%5.52Hold$56.92
Lennar (LEN)
4.3529 of 5 stars
$172.63+1.8%1.16%11.43Hold$181.11
Occidental Petroleum (OXY)
4.8546 of 5 stars
$50.68+0.2%1.74%12.48Hold$65.72
Pfizer (PFE)
4.985 of 5 stars
$27.76-1.2%6.05%37.51Moderate Buy$33.58
Analog Devices (ADI)
4.9808 of 5 stars
$220.00-1.9%1.67%66.07Moderate Buy$249.80
Madison Square Garden Entertainment (MSGE)
2.5103 of 5 stars
$40.54-0.9%N/A13.25Moderate Buy$44.20
Trillium Therapeutics (TRIL)N/AC$0.00-100.0%N/A-34.06N/A
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

ISRG Stock Surges: AI and Healthcare Innovation at the Core
Energy Vault’s 100% Stock Jump: CEO Discusses $350M Project in Australia in MarketBeat CEO Series
Market Shifts After Election: What Stocks Could Benefit Most?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines